Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H32O2 |
Molecular Weight | 316.4776 |
Optical Activity | ( + ) |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@@](O)(CC)[C@@]1(CC)CC[C@]3([H])[C@@]4([H])CCC(=O)C=C4CC[C@@]23[H]
InChI
InChIKey=FTBJKONNNSKOLX-XUDSTZEESA-N
InChI=1S/C21H32O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h13,16-19,23H,3-12H2,1-2H3/t16-,17+,18+,19-,20-,21-/m0/s1
Molecular Formula | C21H32O2 |
Molecular Weight | 316.4776 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Norbolethone is a 19-nor anabolic steroid first synthesized in 1966. During the 1960s it was administered to humans in efficacy studies concerned with short stature and underweight conditions. It has never been reported by doping control laboratories prior to 2001. Norbolethone matches the description for what is described as a "designer steroid. " In fact, Norbolethone was given in clinical trials over 30 years ago and never given the green light. No supply was ever manufactured, and no test was ever developed to detect this substance, yet ironically, it was suspected of being used in the 2000 Olympics based on blood and urine assays done by the IOC. Norbolethone was used in the treatment of idiopathic underweight, prevention of indomethacin-induced intestinal ulcers.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Screening of anabolic steroids in horse urine by liquid chromatography-tandem mass spectrometry. | 2005 Apr 29 |
|
Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry. | 2005 Jul |
|
Structure-activity relationships of synthetic progestins in a yeast-based in vitro androgen bioassay. | 2008 May |
|
A concentration addition model for the activation of the constitutive androstane receptor by xenobiotic mixtures. | 2009 Jan |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:47:03 UTC 2023
by
admin
on
Sat Dec 16 10:47:03 UTC 2023
|
Record UNII |
O60979L83F
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
66255
Created by
admin on Sat Dec 16 10:47:03 UTC 2023 , Edited by admin on Sat Dec 16 10:47:03 UTC 2023
|
PRIMARY | |||
|
m8044
Created by
admin on Sat Dec 16 10:47:03 UTC 2023 , Edited by admin on Sat Dec 16 10:47:03 UTC 2023
|
PRIMARY | Merck Index | ||
|
O60979L83F
Created by
admin on Sat Dec 16 10:47:03 UTC 2023 , Edited by admin on Sat Dec 16 10:47:03 UTC 2023
|
PRIMARY | |||
|
DTXSID801015371
Created by
admin on Sat Dec 16 10:47:03 UTC 2023 , Edited by admin on Sat Dec 16 10:47:03 UTC 2023
|
PRIMARY | |||
|
797-58-0
Created by
admin on Sat Dec 16 10:47:03 UTC 2023 , Edited by admin on Sat Dec 16 10:47:03 UTC 2023
|
PRIMARY | |||
|
89791
Created by
admin on Sat Dec 16 10:47:03 UTC 2023 , Edited by admin on Sat Dec 16 10:47:03 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> ENANTIOMER |
|
||
|
RACEMATE -> ENANTIOMER |
|